Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes

[1]  N. Peel,et al.  Interventions to Optimise Prescribing in Older People with Dementia: A Systematic Review , 2019, Drugs & Aging.

[2]  C. Becker,et al.  Appraising the uptake and use of recommendations for a common outcome data set for clinical trials: a case study in fall injury prevention , 2016, Trials.

[3]  P. Miller,et al.  Interventions to optimise prescribing for older people in care homes. , 2016, The Cochrane database of systematic reviews.

[4]  G. Saade,et al.  A Core Outcome Set for Evaluation of Interventions to Prevent Preterm Birth , 2016, Obstetrics and gynecology.

[5]  R. Autschbach,et al.  A minimum core outcome set for clinical trials on non-minimal-invasive off- or on-pump cardiothoracic surgery , 2015, Trials.

[6]  K. Whale,et al.  The importance of stakeholder selection in core outcome set development: how surveying different health professionals may influence outcome selection , 2015, Trials.

[7]  R. Kane,et al.  Resident- and Facility-Level Predictors of Quality of Life in Long-Term Care. , 2015, The Gerontologist.

[8]  A. Mangoni,et al.  Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis. , 2015, British journal of clinical pharmacology.

[9]  S. Cawthorn,et al.  Development of a core outcome set for research and audit studies in reconstructive breast surgery , 2015, The British journal of surgery.

[10]  M. Koopman,et al.  Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey. , 2015, European journal of cancer.

[11]  R. Sabatowski,et al.  Core outcome set to assess effectiveness in multimodal pain therapy – preliminary results of an interdisciplinary online survey , 2015, Trials.

[12]  P. Williamson,et al.  Core outcome sets and trial registries , 2015, Trials.

[13]  P. Williamson,et al.  A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey , 2015, Trials.

[14]  Humera S. Khan,et al.  Core outcome sets for use in effectiveness trials involving people with bipolar and schizophrenia in a community-based setting (PARTNERS2): study protocol for the development of two core outcome sets , 2015, Trials.

[15]  C. Terwee,et al.  A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set , 2014, Trials.

[16]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[17]  N. Pratt,et al.  Multiple Anticholinergic Medication Use and Risk of Hospital Admission for Confusion or Dementia , 2014, Journal of the American Geriatrics Society.

[18]  R. Gooberman-Hill,et al.  Assessment of chronic post-surgical pain after knee replacement: Development of a core outcome set , 2014, European journal of pain.

[19]  C. Terwee,et al.  Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a ‘core outcome set’ , 2014, Trials.

[20]  Paula R. Williamson,et al.  Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review , 2014, PloS one.

[21]  Nick C Fox,et al.  Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease , 2014, PLoS ONE.

[22]  M. Sprangers,et al.  Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs) , 2014, Trials.

[23]  A. Freitas,et al.  Definition of a core set of quality indicators for the assessment of HIV/AIDS clinical care: a systematic review , 2013, BMC Health Services Research.

[24]  Amy P Abernethy,et al.  Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. , 2013, JAMA internal medicine.

[25]  M. D. de Wit,et al.  Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences , 2013, BMJ Open.

[26]  Elizabeth Gargon,et al.  Can a core outcome set improve the quality of systematic reviews? – a survey of the Co-ordinating Editors of Cochrane review groups , 2013, Trials.

[27]  Jane M Blazeby,et al.  Developing core outcome sets for clinical trials: issues to consider , 2012, Trials.

[28]  P. Williamson,et al.  Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people , 2012, Trials.

[29]  D. Altman,et al.  Driving up the Quality and Relevance of Research Through the Use of Agreed Core Outcomes , 2012, Journal of health services research & policy.

[30]  M. Stellefson,et al.  Advantages and Limitations of the e-Delphi Technique , 2012 .

[31]  Gordon H Guyatt,et al.  GRADE guidelines: 2. Framing the question and deciding on important outcomes. , 2011, Journal of clinical epidemiology.

[32]  N. Kerse,et al.  Prescribing for older people in nursing homes: a review of the key issues. , 2011, International journal of older people nursing.

[33]  A. Majeed,et al.  Interventions to optimise prescribing in care homes: systematic review. , 2011, Age and ageing.

[34]  P. Williamson,et al.  Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies , 2011, PLoS medicine.

[35]  C. Terwee,et al.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study , 2010, Quality of Life Research.

[36]  Douglas G Altman,et al.  The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews , 2010, BMJ : British Medical Journal.

[37]  Martin Kendall,et al.  Chairman of the Joint Formulary Committee, British National Formulary. , 2009, Clinical medicine.

[38]  P. Minuz,et al.  Medication errors: prescribing faults and prescription errors. , 2009, British journal of clinical pharmacology.

[39]  P. Gallagher,et al.  Inappropriate prescribing and adverse drug events in older people , 2009, BMC geriatrics.

[40]  David A. Williams,et al.  Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. , 2008, Arthritis and rheumatism.

[41]  M. Boustani,et al.  Impact of anticholinergics on the aging brain: a review and practical application , 2008 .

[42]  P. Gallagher,et al.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. , 2008, International journal of clinical pharmacology and therapeutics.

[43]  Allen Huang,et al.  The challenge of managing drug interactions in elderly people , 2007, The Lancet.

[44]  Nick Barber,et al.  Appropriate prescribing in elderly people: how well can it be measured and optimised? , 2007, The Lancet.

[45]  S. Rubin,et al.  A drug burden index to define the functional burden of medications in older people. , 2007, Archives of internal medicine.

[46]  P. Barry,et al.  Inappropriate prescribing in the elderly , 2007, Journal of clinical pharmacy and therapeutics.

[47]  L. Rubenstein.  Falls in older people: epidemiology, risk factors and strategies for prevention. , 2006, Age and ageing.

[48]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[49]  M. Beers,et al.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.

[50]  I J Higginson,et al.  Using quality of life measures in the clinical setting , 2001, BMJ : British Medical Journal.

[51]  H. Sintonen.  The 15D instrument of health-related quality of life: properties and applications , 2001, Annals of medicine.

[52]  N. Barber,et al.  What is a prescribing error? , 2000, Quality in health care : QHC.

[53]  M. O'Mahony,et al.  Frailty and ageing. , 1997, Age and ageing.

[54]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[55]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[56]  A. B. Prasad,et al.  British National Formulary , 1994 .

[57]  H. Cohen,et al.  A method for assessing drug therapy appropriateness. , 1992, Journal of clinical epidemiology.

[58]  L. Fallowfield.  The quality of life : the missing measurement in health care , 1991 .

[59]  P. Steerenberg,et al.  Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. , 2010, Annals of the rheumatic diseases.

[60]  J. Malley,et al.  Younger Adults' Understanding of Questions for a Service User Experience Survey. Funded/commissioned by: The Health and Social Care Information Centre , 2006 .

[61]  S D Small,et al.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. , 1995, JAMA.

[62]  C. R. Snyder.  The Quality of Life: The Missing Measurement in Health Care. , 1992 .